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Abstract 
Patients with tricuspid atresia and ventricular septal defect have in the past occasionally 
undergone a Fontan with “Björk” modification to create a connection between the right atrium 
and the right ventricular outflow tract. While rarely performed now, patients with this physiology 
often face severe complications requiring re-intervention. We hypothesize that surgical 
conversion to a 2-ventricle or 1.5-ventricle circulation can improve hemodynamics, clinical 
status, and thus increase time to transplant. We present two successful cases to illustrate this 
idea. 
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Surgical interventions for patients with single ventricle congenital heart disease have evolved 
over time. Patients with tricuspid atresia (TA) and ventricular septal defect (VSD) occasionally 
are treated with the “Björk” modification, which includes creation of a valveless right atrial (RA) 
to right ventricular outflow tract (RVOT) communication [1]. Long-term complications occur due 
to the free regurgitant flow, calcification and/or stenosis of the homograft, RA dilatation, atrial 
arrhythmias, liver congestion, thromboembolism, and ventricular dysfunction [2,3].  In the 
majority of patients after Björk modification, no additional surgery is considered, other than 
orthotopic heart transplant. We present two cases of successful Fontan take-down to either a 
1.5-ventricle or 2-ventricle anatomy late after Björk operations.  
 
Case Reports 
Case 1 
A man born with TA and VSD presented with signs and symptoms of a failing Fontan at age 32 
years. In infancy he had undergone bilateral Blalock-Taussig shunt placement followed by 
Fontan with Björk modification at four years of age. Figure 1A demonstrates forward flow 
through the RVOT and Figure 1B shows reverse flow. By age 17 years, the patient had 
developed significant RA dilatation, recurrent atrial flutter, and sinus node abnormalities 
requiring pacemaker. He was New York Heart Association (NYHA) class II. Echocardiogram 
revealed moderately dilated RV with right ventricular end diastole (RVDD) measuring 3.42 cm 
with mildly diminished function. He underwent placement of a 29-mm porcine valve in the 
“tricuspid” position in the RA-RVOT conduit and concurrent radiofrequency atrial maze 
procedure, converting him to 2-ventricle physiology. Echocardiographic image in Figure 2 
demonstrates unobstructed flow through the implanted valve in the RA-RVOT conduit. RV size 
and function remained stable with RVDD measuring 3.49 cm. Post-operatively, NYHA class 
improved to class I within 6 weeks. He had some recurrence of atrial flutter that was managed 
medically. He clinically did well for 15 years until degradation of tissue valve led to biventricular 
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dysfunction, recurrent atrial flutter, and right pleural effusion. At 32-years-old he underwent 
tricuspid valve replacement with further radiofrequency atrial ablation and has been doing well 
without hospital readmission since re-operation fifteen months ago. 
 
Case 2 
A man born with TA and VSD presented with signs and symptoms of a failing Fontan at age 42 
years. He had undergone left BT shunt in infancy, Waterston shunt at six-years-old, and Fontan 
with Björk modification at nine-years-old. By age 42 years, he developed RA enlargement 
complicated by permanent atrial fibrillation and liver congestion. He underwent cardiac MRI, 
which revealed RV end-diastolic volume of 73 mL/m2 and ejection fraction of 31% with an 
RV:LV end-diastolic volume ratio of 1. He was NYHA class II-III. He underwent Fontan 
conversion with creation of a 1.5-ventricle circulation by creating a bidirectional Glenn 
anastomosis (superior vena cava to pulmonary artery) and implanting a 29-mm porcine valve 
between the RA appendage and the RVOT as can be seen in Figure 3. He had a 
radiofrequency maze procedure performed during the same operation but unfortunately 
remained in atrial fibrillation post-operatively albeit with improved rate control. He has done well 
post-operatively without hospital readmission in the ten months since Fontan conversion and is 
now NYHA class I. 
 
Comment 
Surgical interventions for single ventricle patients, specifically TA with VSD patients, has 
evolved over the past few decades. While Björk-Fontans are rarely performed now, there are 
patients who are now adults facing the long-term consequences of Björk circulation. There are 
currently no guidelines as to when to intervene or what intervention to conduct. A transplant 
would be the most definitive therapy. However, given the lack of donor organs for patients with 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
complex congenital heart disease and the comorbidities associated with transplantation, 
strategies to delay transplant or alternatives to transplant are clearly needed.  
Ono et. al. reviewed 41 patients with Fontan-Björk physiology and identified positive 
clinical and hemodynamic results from having pulsatile flow from the RV to the PA, including 
fewer interventions for tachyarrhythmias, higher oxygen uptake on exercise stress testing, 
higher systolic PA pressure, and decreased cardiac decompensation compared to those with 
non-pulsatile flow [4]. Thus, for patients with adequate RV size and function, placement of a 
valve in the “tricuspid” position resulting in conversion to a 1.5- or 2-ventricle system could 
reduce complications of Fontan physiology or prolong time for need for transplant. 
For some patients with Fontan-Björk physiology who face complications due to the 
regurgitant flow in the RA-RV connection, a percutaneous valve in the “tricuspid” position is a 
possible intervention [2,5-7]. Shah et al. described 16 patients who underwent percutaneous 
valve implantation for RA-RV regurgitation and RA dilation. While these patients showed 
hemodynamic improvement, the patients who remained symptomatic were those with 
uncontrolled atrial flutter [2]. Studies have shown that patients who undergo Fontan conversion 
with surgical treatment of tachyarrhythmias at the time of Fontan conversion are superior to 
conversion without arrhythmia surgery [3,8]. Therefore, for these two patients who had 
developed RA dilatation from the regurgitant flow inherent to Björk physiology that was 
complicated by recurrent or permanent atrial arrhythmias, the team of surgeons and 
cardiologists offered surgical conversion with combined atrial arrhythmia surgery. 
The first patient underwent a 2-ventricle repair because he had reasonable RV size and 
function and the second underwent a 1.5-ventricle repair because of concern that it would be 
difficult to come off bypass postoperatively without a Glenn due to small RV size and decreased 
RV function. Both patients underwent maze procedures for treatment of medically-resistant 
arrhythmias. Because they needed arrhythmia intervention, percutaneous valve placement was 
felt not to be a good option.  
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These two cases illustrate a surgical option for 1.5- or 2-ventricle Fontan conversion in 
selected patients with the Björk modifications who either would benefit from atrial arrhythmia 
surgery or for those who are otherwise not candidates for percutaneous placement of a valve in 
the tricuspid position. While data is limited in this subset of patients, we hypothesize that 
implanting a durable valve in this location would reduce complications from Fontan-Björk 
circulation, namely liver congestion and right atrial dilatation with resultant atrial arrhythmias.  
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Figure legends 
Figure 1: Echocardiogram images of the Björk modification with A showing forward flow through 
the RVOT and B showing reverse flow. 
Figure 2: Echocardiogram image showing unobstructed flow through the “tricuspid valve” in the 
RA-RV conduit. 
Figure 3: Cardiac MRI data with A showing the pre-operative SVC to RA junction and B shows 
the post-operative SVC to PA anastomosis, smaller RA, and new porcine bioprosthetic 
“tricuspid valve.” 
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